BioPharmSignal logoBioPharmSignal

Biotech News

Tactile Medical to Release Fourth Quarter and Fiscal Year 2025 Financial Results on February 17, 2026

Tactile Systems Technology, Inc. (TCMD)Tactile Systems Technology, Inc.Earnings

MINNEAPOLIS, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that fourth quarter and fiscal year 2025 financial results will be

Related news

TCMDTactile Systems Technology, Inc.2026-07-21 20:05 EST

Tactile Medical to Release Second Quarter of Fiscal Year 2026 Financial Results on August 10, 2026

TCMDTactile Systems Technology, Inc.2026-08-10 20:05 EST

Tactile Systems Technology, Inc. Reports Second Quarter 2026 Financial Results

ANGOAngioDynamics2026-07-14 10:00 EST

AngioDynamics Reports Record Fiscal Year 2026 Fourth Quarter and Full Year Financial Results; Continued Execution Drives Med Tech Growth and Full-Year Profitability

ANGOAngioDynamics2026-06-30 12:00 EST

AngioDynamics to Report Fiscal 2026 Fourth Quarter and Full-Year Financial Results on July 14, 2026

XAIRBeyond Air2026-06-26 11:00 EST

Beyond Air® Reports Fourth Quarter and Full Year 2026 Financial Results and Provides Corporate Update

FEMYFEMASYS2026-08-14 20:05 EST

Femasys Announces Financial Results for Quarter Ended June 30, 2026 and Provides Corporate Update

XAIRBeyond Air2026-08-13 11:00 EST

Beyond Air® Reports Financial Results for the Quarter Ended June 30, 2026 and Provides Corporate Update

STIMNeuronetics2026-08-11 11:50 EST

Neuronetics Reports Second Quarter 2026 Financial and Operating Results

CVRXCVRx2026-08-06 20:05 EST

CVRx Reports Second Quarter 2026 Financial and Operating Results

PLSEPulse Biosciences2026-08-06 20:05 EST

Pulse Biosciences Reports Business Updates and Second Quarter 2026 Financial Results

View all latest news

Tactile Systems Technology, Inc.

At-Home Chronic-Care Therapies Tactile Medical develops and markets at-home therapies for underserved chronic conditions. Its products help patients manage long-term diseases outside hospitals and clinics while supporting clinician-directed treatment plans. Lymphedema Portfolio The company's Flexitouch systems deliver pneumatic...

Recent company news

TCMDTactile Systems Technology, Inc.2026-08-10 20:05 EST

Tactile Systems Technology, Inc. Reports Second Quarter 2026 Financial Results

TCMDTactile Systems Technology, Inc.2026-07-21 20:05 EST

Tactile Medical to Release Second Quarter of Fiscal Year 2026 Financial Results on August 10, 2026

TCMDTactile Systems Technology, Inc.2026-07-13 12:00 EST

Tactile Medical Enters Exclusive U.S. Distribution Agreement with ElastiMed for its MyoSleeve™ Wearable Compression Device for VA and DoD Patients

TCMDTactile Systems Technology, Inc.2026-06-02 12:00 EST

Tactile Medical Launches Next-Generation AffloVest® Airway Clearance Therapy

TCMDTactile Systems Technology, Inc.2026-05-20 20:05 EST

Tactile Medical to Present at the William Blair 46th Annual Growth Stock Conference

Stock data

Close
23.82 USD
Market cap
550.6M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States